Do normal C-reactive protein levels exclude the diagnosis of cryptococcal meningitis?
To the Editor: South Africa is presently experiencing an epidemic of HIV-associated diseases, including cryptococcal meningitis. Cryptococcus is a fungal-type organism, and disseminated or cryptococcal meningitis is an AIDS-defining disease, occurring in up to 10% of patients with AIDS. In Durban, South Africa, cryptococcal meningitis was the initial AIDS-defining illness in 84% of HIV patients, 1 while in Pretoria it was found to be the presenting cause for patients with HIV and meningitis in 50% of patients.
2 Its incidence at Pretoria academic hospitals has more than doubled over the past year (Levay, unpublished findings). The clinical presentation of patients with cryptococcal meningitis varies from headache (>95%) to coma. The diagnosis of cryptococcal meningitis presently rests on lumbar puncture demonstrating cryptococcal organisms by smear, antigen or culture. This is an invasive and costly procedure and is associated with patient discomfort. It would be ideal if a screening test could be used to exclude this diagnosis based on a simple blood examination, such as C-reactive protein (CRP). This test would mean less discomfort for the patient, in addition to decreased laboratory examination costs, especially as the patients may present with a mild symptom such as headache.
To determine the usefulness of serum CRP levels in patients with cryptococcal meningitis on the day of presentation, a retrospective analysis was done on patients with cryptococcal meningitis. Following ethical clearance from the Ethical Committee of the University of Pretoria, patients were identified by searching the database of the Institute of Pathology at the University of Pretoria. Patients with laboratory tests indicative of cryptococcal meningitis (gold standard criterion used for diagnosis is a positive cerebrospinal fluid culture, antigen or cryptococcal smear) and a CRP level on the day of the spinal tap were included (see Table I ). A normal serum CRP value was defined as ≤ 10 mg/l. The data were computerised and statistically analysed using Statistica 6.0.
Of the 308 patients with cryptococcal meningitis that were found in the database, 204 had CRP values for the day on which the lumbar puncture and diagnosis were done. Of these, 72 (35.29%) had CRP levels that were within normal levels ( Figure 1 ). This indicates a sensitivity of 64.71% for elevated CRP for the diagnosis of cryptococcal meningitis diagnosis. Specificity was not calculated.
In the case of certain infections, such as Pneumocystis jiroeici pneumonia, CRP levels have been reported to be significantly lower in HIVpositive patients in comparison to HIVnegative patients. 3 There is some evidence that HIV-infected patients may have a suboptimal immune response to infections with lower CRP levels. 4, 5 CRP values in HIV-positive patients with cryptococcal meningitis may therefore have been decreased falsely. Our findings indicate that CRP is a poor screening test for cryptococcal meningitis, missing more than a third of episodes.
In conclusion, our findings do not substantiate CRP as a good screening tool for patients who may present with cryptococcal meningitis. Lumbar punctures should be considered in all patients with a high risk (e.g. HIV) and with symptoms, however mild (e.g. headache), and remain the gold standard for the diagnosis of cryptococcal meningitis. 
